{
    "nctId": "NCT02613026",
    "briefTitle": "Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast Cancer",
    "officialTitle": "Comparative Analysis of the Efficacies of AT and AC-T Regimens in Neoadjuvant Chemotherapy of Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 104,
    "primaryOutcomeMeasure": "pathological complete response rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* histopathologically diagnosed with stage I-III breast cancers;\n* clearly confirmed ER, PR and HER2 statuses;\n* the state of axillary lymph nodes was determined through the relevant examination steps (puncture or sentinel lymph node biopsy);\n* the patients were not treated with neoadjuvant therapy and surgery.\n\nExclusion Criteria:\n\n* the patients whose breasts or axillary lumps had received excision biopsy;\n* the patients who had severely abnormal organ functions or who could not tolerate chemotherapy,\n* the patients with severe concomitant diseases;\n* the patients with heart disease or left ventricular ejection fraction (LVEF) \\<50%.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}